Galt Pharma Exports Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 2.00 Cr
- Company Age 20 Year, 1 Month
- Last Filing with ROC 31 Mar 2020
- Satisfied Charges ₹ 11.45 Cr
- Revenue Growth -87.87%
- Profit Growth -13.73%
- Ebitda 74.76%
- Net Worth 0.91%
- Total Assets -11.20%
About Galt Pharma Exports
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909TG2005PTC045074
- Company No.
045074
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jan 2005
- Date of AGM
30 Sep 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc-Hyderabad
Industry
Who are the key members and board of directors at Galt Pharma Exports?
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Galt Pharma Exports.
Galt Pharma Exports Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 87.87% decrease. The company also saw a substantial fall in profitability, with a 13.73% decrease in profit. The company's net worth moved up by a moderate rise of 0.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Galt Pharma Exports?
In 2020, Galt Pharma Exports had a promoter holding of 99.95% and a public holding of 0.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹11.45 Cr
Charges Breakdown by Lending Institutions
- Citi Bank N.A. : 7.25 Cr
- Hdfc Bank Limited : 4.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jul 2014 | Citi Bank N.A. | ₹7.25 Cr | Satisfied |
| 05 Oct 2012 | Hdfc Bank Limited | ₹4.20 Cr | Satisfied |
How Many Employees Work at Galt Pharma Exports?
Unlock and access historical data on people associated with Galt Pharma Exports, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Galt Pharma Exports, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Galt Pharma Exports's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
